Hypothesize That!

Deep in the shadowy corridors of laboratories and the silent pages of medical journals, progress can falter, not for lack of brilliance, but because of the systems surrounding it. Ideas are delayed, discoveries are hidden, and bold thinking is quietly discouraged. This is Crimes Against Innovation.   Join Professor Maddie Parsons and Dr Graham Price as they go head-to-head on two major offend...

Are today’s clinical trials fit for the future of medicine, or are they holding innovation back?   In this episode, host Nicola Hill, is joined by Professor Maddie Parsons, Dean of Research Excellence Frameworks at King’s College London, and Dr Graham Price, Head of Global Clinical Development at UCB, to examine whether today’s trials are fit for tomorrow’s science.   Listen to our guest...

In the darkened corridors of laboratories and the silent pages of medical journals, there are stories rarely spoken about—tales of brilliance that burned too bright, and ideas that strayed into catastrophe. This is— Crimes Against Innovation .   Laurence Woollard and Dr. Emma Lane debate two pressing issues in healthcare: the under-representation of women in clinical trials and the misleading...

Is scientific innovation enough to drive the future of gene therapy, or is patient engagement the missing key? Join host Nicola Hill as she explores this question with Laurence Woollard, a rare disease advocate, and UCB’s Global Patient Engagement Lead, Dr. Emma Lane. Together, they discuss the critical role of patients in co-creating therapies that meet real-world needs, the ethical challenges of...

In the shadowy corridors of laboratories and the silent pages of medical journals, there lie tales that have seldom been told. Tales of ambition that flew too close to the sun, of genius that turned into folly, and of innovation that... well, wasn't quite so innovative. This is— Crimes Against Innovation .   Join Craig Lipset and Lewis Millen as they argue two distinct crimes against innovati...

Could the clinical trials of the future operate seamlessly in the background of our daily lives? In this episode, host Nicola Hill explores the hypothesis that fully virtualised decentralized clinical trials (DCT), that operate invisibly, will make traditional models obsolete within the next decade.   Joining her are Craig Lipset, Co-Chair of the Decentralized Trials and Research Alliance, an...

Deep in the shadowy corridors of laboratories and the silent pages of medical journals, secrets lie waiting to be uncovered - tales of ambition that soared too high to the sun, ideas that derailed progress, and innovations that should never have seen the light of day. This is Crimes Against Innovation .   In this episode, Professor Russ Altman and Dr. Alistair Henry go head-to-head as they de...

In this episode, we tackle a transformative question: will traditional wet labs be rendered obsolete by digital and AI-powered innovations? Host Nicola Hill is joined by Professor Russ Altman from Stanford University, and Dr. Alistair Henry, UCB’s Chief Scientific Officer, to debate the rise of virtual pharmaceutical research.   Discover how technologies like machine learning, in silico compo...